Health-Related Quality of Life of Patients with Metastatic Pancreatic Cancer: A Systematic Literature Review

Health-Related Quality of Life of Patients with Metastatic Pancreatic Cancer: A Systematic Literature Review

Hyun Kyoo Yoo,1 Nikunj Patel,2 Seongjung Joo,3 Suvina Amin,2 Rowena Hughes,4 Rajinder Chawla5 1Health Economics & Payer Evidence AstraZeneca, Cambridge, UK; 2Oncology Business Unit, AstraZeneca, Gaithersburg, MD, USA; 3MRL, Center for Observational & Real-World Evidence (CORE), Oncology, Mer...

Full description

Bibliographic Details
Main Authors:	Yoo HK, Patel N, Joo S, Amin S, Hughes R, Chawla R
Format:	Article
Language:	English
Published:	Dove Medical Press 2022-12-01
Series:	Cancer Management and Research
Subjects:	health-related quality of life metastatic pancreatic cancer symptoms
Online Access:	https://www.dovepress.com/health-related-quality-of-life-of-patients-with-metastatic-pancreatic--peer-reviewed-fulltext-article-CMAR

Similar Items

Quality of life study of patients with unresectable locally advanced or metastatic pancreatic adenocarcinoma treated with gemcitabine+nab-paclitaxel versus gemcitabine alone: AX-PANC-SY001, a randomized phase-2 study
by: Suayib Yalcin, et al.
Published: (2020-03-01)

Metastatic Pancreatic Cancer: Where Are We?
by: Abraham Hernández-Blanquisett, et al.
Published: (2024-01-01)

Living with Metastatic Cancer: A Roadmap for Future Research
by: Danielle B. Tometich, et al.
Published: (2020-12-01)

The Role of Immune Checkpoint Inhibitors in Metastatic Pancreatic Cancer: Current State and Outlook
by: Linh Chi Tran, et al.
Published: (2023-10-01)

Real-Life Results of Palliative Chemotherapy in Metastatic Pancreatic Ductal Adenocarcinoma
by: Bianca Varzaru, et al.
Published: (2023-07-01)

Prediction Model of the Quality of Life for Patients with Pancreatic Cancer
by: Jisun Lee
Published: (2022-10-01)

Hemostasis with Metallic Stent for Multiple Metastatic Pancreatic Tumors Complicated with Hemobilia
by: Hiroyuki Ito, et al.
Published: (2024-02-01)

Metastatic pancreatic adenocarcinomas could be classified into M1a and M1b category by the number of metastatic organs
by: Fang Feng, et al.
Published: (2020-08-01)

Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study
by: Ana Fernández, et al.
Published: (2018-11-01)

Symptoms and quality of life among men starting treatment for metastatic castration-resistant prostate cancer – a prospective multicenter study
by: Ulrika Rönningås, et al.
Published: (2024-03-01)

Impact of Sarcopenia on Survival in Patients Treated with FOLFIRINOX in a First-Line Setting for Metastatic Pancreatic Carcinoma
by: Lisa Lellouche, et al.
Published: (2023-03-01)

Impact on health‐related quality of life deterioration‐free survival of a first‐line therapy combining nab‐paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the randomized phase II AFUGEM GERCOR clinical trial
by: Emilie Charton, et al.
Published: (2019-09-01)

Health state utility values for metastatic pancreatic cancer using a composite time trade-off based on the vignette-based approach in Japan
by: Takumoto Yuki, et al.
Published: (2022-12-01)

Health-related quality of life scores of metastatic pancreatic cancer patients responsive to first line chemotherapy compared to newly derived EORTC QLQ-C30 reference values
by: Suvina Amin, et al.
Published: (2022-05-01)

The role of FOLFIRINOX in metastatic pancreatic cancer: a meta-analysis
by: Beilei Zhang, et al.
Published: (2021-06-01)

Locoregional Treatment of Metastatic Pancreatic Cancer Utilizing Resection, Ablation and Embolization: A Systematic Review
by: Florentine E. F. Timmer, et al.
Published: (2021-03-01)

Optimizing First-Line Chemotherapy in Metastatic Pancreatic Cancer: Efficacy of FOLFIRINOX versus Nab-Paclitaxel Plus Gemcitabine
by: Francesco Di Costanzo, et al.
Published: (2023-01-01)

Transformation of pancreatic nonfunctioning neuroendocrine tumor into metastatic insulinoma: A rare case report
by: Venkata S. Buddhavarapu, et al.
Published: (2023-11-01)

Alternating Gemcitabine/Nab-Paclitaxel (GA) and 5-FU/Leucovorin/Irinotecan (FOLFIRI) as First-Line Treatment for De Novo Metastatic Pancreatic Cancer (MPC): Safety and Effect
by: Brett A. Schroeder, et al.
Published: (2023-11-01)

An Unexpected Tumor Reduction: Treatment with Olaparib Monotherapy in Heavily Pretreated BRCA2 Mutated Metastatic Pancreatic Cancer
by: Alessandra Anna Prete, et al.
Published: (2022-01-01)

Individualized Prediction of Survival Benefits of Pancreatectomy Plus Chemotherapy in Patients With Simultaneous Metastatic Pancreatic Cancer
by: Duorui Nie, et al.
Published: (2021-09-01)

The Liver Pre-Metastatic Niche in Pancreatic Cancer: A Potential Opportunity for Intervention
by: Peter Gumberger, et al.
Published: (2022-06-01)

Results of a Randomized, Double-Blind, Placebo-Controlled, Phase 1b/2 Trial of Nabpaclitaxel + Gemcitabine ± Olaratumab in Treatment-Naïve Participants with Metastatic Pancreatic Cancer
by: Faithlore P. Gardner, et al.
Published: (2024-03-01)

Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practice
by: Berta Laquente, et al.
Published: (2020-07-01)

Unusual Case of Pancreatic Adenocarcinoma with Bladder Metastasis
by: Giorgia Arcovito, et al.
Published: (2020-12-01)

Orbital metastasis as the primary manifestation of pancreatic carcinoma: a case report and literature review
by: Tatsuro Yokoyama, et al.
Published: (2022-03-01)

The Impact of Bevacizumab and Chemotherapy on Quality of Life in Metastatic Colorectal Cancer Patients
by: Diana Cornelia Moisuc, et al.
Published: (2023-02-01)

Cost-Effectiveness Analysis of Olaparib Maintenance Treatment for Germline BRCA-Mutated Metastatic Pancreatic Cancer
by: Na Li, et al.
Published: (2021-04-01)

Activity and Safety of NAB-FOLFIRI and NAB-FOLFOX as First-Line Treatment for metastatic Pancreatic Cancer (NabucCO Study)
by: Elisa Giommoni, et al.
Published: (2021-05-01)

Comparative effectiveness and resource utilization of nab-paclitaxel plus gemcitabine vs FOLFIRINOX or gemcitabine for the first-line treatment of metastatic pancreatic adenocarcinoma in a US community setting
by: Braiteh F, et al.
Published: (2017-04-01)

A Near-Complete Response to Treatment with Gemcitabine plus nab®-Paclitaxel in a Patient with Metastatic Pancreatic Cancer and Poor Performance Status: A Case Report
by: Abdur R. Shakir
Published: (2014-10-01)

FES null mice demonstrate a reduction in neutrophil dependent pancreatic cancer metastatic burden
by: Jan E. Strøbech, et al.
Published: (2023-03-01)

Quality of life and its predictors among patients with metastatic cancer in Bangladesh: the APPROACH survey
by: Rubayat Rahman, et al.
Published: (2024-01-01)

The efficacy and safety of Nab-paclitaxel plus gemcitabine versus mFOLFIRINOX in the first-line treatment of metastatic pancreatic cancer: a retrospective study
by: Lei Yang, et al.
Published: (2023-01-01)

Pancreatic Cancer Malnutrition and Pancreatic Exocrine Insufficiency in the Course of Chemotherapy in Unresectable Pancreatic Cancer
by: Mariia Kiriukova, et al.
Published: (2020-09-01)

First-line chemotherapy regimens for locally advanced and metastatic pancreatic adenocarcinoma: a Bayesian analysis
by: Zhang S, et al.
Published: (2018-11-01)

Impacts of systemic treatments on health-related quality of life for patients with metastatic colorectal cancer: a systematic review and network meta-analysis
by: Yunlin Jiang, et al.
Published: (2024-02-01)

The Relation between the Severity of Pain and Common Symptoms in Patients with Metastatic Cancer
by: Nehal El-Sayed, et al.
Published: (2018-06-01)

The Effect of Pain Self-Management Education on Pain Severity and Quality of Life in Metastatic Cancer Patients
by: Mahsa Musavi, et al.
Published: (2021-01-01)

Phase I/II Study of LDE225 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer
by: Esther N. Pijnappel, et al.
Published: (2021-09-01)